about
Heterogeneity of macrophage infiltration and therapeutic response in lung carcinoma revealed by 3D organ imaging.Histidine decarboxylase (HDC)-expressing granulocytic myeloid cells induce and recruit Foxp3+ regulatory T cells in murine colon cancer.Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer.Macrophage PPARγ inhibits Gpr132 to mediate the anti-tumor effects of rosiglitazone.TAK1 regulates resident macrophages by protecting lysosomal integrity.Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook.The Promise of Targeting Macrophages in Cancer Therapy.Myeloid cells as a target for oligonucleotide therapeutics: turning obstacles into opportunities.Macrophage Metabolism As Therapeutic Target for Cancer, Atherosclerosis, and Obesity.Progress in tumor-associated macrophage (TAM)-targeted therapeutics.Imaging of anticancer drug action in single cells.Regulatory myeloid cells: an underexplored continent in B-cell lymphomas.In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy.Crosstalk between stromal components and tumor cells of TNBC via secreted factors enhances tumor growth and metastasis.Workshop on challenges, insights, and future directions for mouse and humanized models in cancer immunology and immunotherapy: a report from the associated programs of the 2016 annual meeting for the Society for Immunotherapy of cancer.PF4 Promotes Platelet Production and Lung Cancer Growth.Roles for Innate Immunity in Combination Immunotherapies.Targeting CXCR4-dependent immunosuppressive Ly6Clow monocytes improves antiangiogenic therapy in colorectal cancerPD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy.Use of Angiotensin System Inhibitors Is Associated with Immune Activation and Longer Survival in Nonmetastatic Pancreatic Ductal Adenocarcinoma.Toll-like receptor 2 ligand and interferon-γ suppress anti-tumor T cell responses by enhancing the immunosuppressive activity of monocytic myeloid-derived suppressor cells.Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment.Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications.Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils.Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascular bursts.Contribution of Adipose Tissue to Development of Cancer.The tumour microenvironment creates a niche for the self-renewal of tumour-promoting macrophages in colon adenoma.Immunological hallmarks of cis-DDP-resistant Lewis lung carcinoma cells.Exercise-dependent regulation of the tumour microenvironment.Phenotypical change of tumor-associated macrophages in metastatic lesions of clear cell renal cell carcinoma.NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control.Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses.Innate allorecognition by monocytic cells and its role in graft rejection.Targeting the ubiquitin-conjugating enzyme E2D4 for cancer drug discovery-a structure-based approach.Generation of a double binary transgenic zebrafish model to study myeloid gene regulation in response to oncogene activation in melanocytes.Macrophages: The Road Less Traveled, Changing Anticancer Therapy.A Phase I study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumours.MK2 contributes to tumor progression by promoting M2 macrophage polarization and tumor angiogenesis.Leukocyte-derived biomimetic nanoparticulate drug delivery systems for cancer therapy.
P2860
Q30838654-D69E6590-9B0F-4453-86B5-3F76966B7FBAQ34555169-A26F9508-FA70-4CDA-B0E1-780F099C8D85Q36283286-389C89F3-9F01-4544-8BEA-59E0916F065EQ37306048-3EAE094B-38DF-414A-8CC5-57B9C7618170Q37745189-6047690B-5531-4020-B8F8-923C59A13EE3Q38677432-18D737EA-7516-44C6-81F1-4598A085C0AFQ38877313-74F04879-DB06-4643-94F8-01FACFE00887Q38953721-9891E88F-23CB-40A6-ACB9-0B6CD0C5CAEEQ39210018-34B6939A-747D-4EDB-A658-B572F363B3A2Q39267549-8F31FCC7-3697-4F74-A11A-5B0BF664B61EQ39392711-2EA7F034-208B-49A5-96DC-6837FE1D2926Q39423479-8F8DB97D-AB9C-4781-BD7A-8E350C0F2B68Q40218347-0ED24DB6-F262-41B0-8EAB-66D82338D9E4Q41694184-B69C22AD-D402-4DB2-9724-A267E7F2E97BQ41706958-82291924-7B97-46B2-A738-B25ACE48A3FBQ41849208-F5559ADB-4476-4FE8-ACF7-9CEAE92A4EE3Q41996352-70FD0630-89E9-4E7D-90A8-98B69A68F6B2Q42284089-6D20B0B3-9585-4DD0-B07D-F312FF52126FQ42325128-E3981736-8A6D-4BA8-A223-47B86911FF3EQ42776799-6A9205D5-C5EE-43E1-8CAD-47CF14C60ACEQ47123300-965420BA-4797-49DF-8FBB-1423A8BF541FQ47146426-4E97D2ED-69F5-4511-BDC8-336E3413EDEEQ47325431-1E406E29-FAC5-41F7-950D-786F01D8B2E8Q47962563-2E02821C-6B5E-44B1-A40C-05024162E9D3Q48207560-001C45BE-27D9-4312-AA83-EA2B80D7F250Q48348656-04710AB4-2F5A-4E40-ADA7-2973573B80F5Q49164235-53093B2F-F95F-4468-8E09-65615CC88D81Q49310867-1B9713F3-4F91-4642-99B9-06B5DC11B275Q49382862-959E54BF-269D-4A99-B92F-5A9A19DB3DB6Q49875257-44401FFB-3035-46F7-85F5-1D794F1AD687Q50017705-372B4007-7F87-4003-B3DD-F8E6F9C1C8AAQ50076191-CD63B9A5-F201-4D28-8456-C039A53B4161Q50647447-D013DD3F-906D-4C09-BC90-596B3094A0BFQ50882603-57B1AE75-836C-4E7E-96F3-B7B6E758F1F9Q51061506-B1A68188-8EB5-4877-A218-92A327659E0FQ52318763-30BB0C59-CBA2-4B75-959F-F06658A62EBEQ52321369-48BB5FDE-0A34-4B6C-82FB-B414B97FFEA7Q52659459-04C80CBA-A16D-48D1-B038-5B31A561B8D5Q52718712-E81C72EE-B743-4A1C-A1F5-4F4753805853Q55150815-3C0DF96D-D0DD-488F-8C2D-7E08EB0407DC
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The role of myeloid cells in cancer therapies.
@en
type
label
The role of myeloid cells in cancer therapies.
@en
prefLabel
The role of myeloid cells in cancer therapies.
@en
P2093
P2860
P356
P1476
The role of myeloid cells in cancer therapies.
@en
P2093
Camilla Engblom
Christina Pfirschke
Mikael J Pittet
P2860
P2888
P304
P356
10.1038/NRC.2016.54
P407
P577
2016-07-01T00:00:00Z
P6179
1030891341